Xylem is trading at $104.08, down 4.20%, amid broad U.S. equity weakness and Treasury yields near 5.14%.

  • On September 24, 2026, the S&P 500 fell 0.55%, the Nasdaq 0.82%, and the Dow 0.70%; Xylem underperformed.
  • Strong business activity reinforced expectations for elevated rates, pressuring equity valuations; no clear company-specific catalyst was identified.
  • Xylem’s recent $1.5 billion senior-notes offering, announced September 15, remains relevant balance-sheet context.